Arrowstreet Capital, Limited Partnership Ngm Biopharmaceuticals Inc Transaction History

Arrowstreet Capital, Limited Partnership

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $476,909 - $669,339	37,880 Added 270.9%	51,863 $678,000
Q2 2022 Aug 15, 2022	BUY	$10.58 - $17.5 $147,940 - $244,702	13,983 New	13,983 $179,000
Q3 2020 Nov 12, 2020	SELL	$15.59 - $19.97 $1.26 Million - $1.62 Million	-81,016 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$11.97 - $23.47 $969,761 - $1.9 Million	81,016 New	81,016 $1.6 Million

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.